Investment House LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Investment House LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$144.95 - $152.29 $436,299 - $458,392	-3,010 Reduced 55.38%	2,425 $367,000
Q4 2021 Feb 09, 2022	SELL	$99.73 - $148.48 $174,527 - $259,839	-1,750 Reduced 24.36%	5,435 $749,000
Q1 2021 May 06, 2021	SELL	$64.07 - $91.75 $36,840 - $52,756	-575 Reduced 7.41%	7,185 $491,000
Q4 2020 Jan 13, 2021	BUY	$65.07 - $98.24 $23,425 - $35,366	360 Added 4.86%	7,760 $665,000
Q3 2020 Nov 06, 2020	BUY	$59.04 - $77.95 $35,424 - $46,770	600 Added 8.82%	7,400 $481,000
Q2 2020 Jul 13, 2020	BUY	$29.01 - $74.23 $197,268 - $504,764	6,800 New	6,800 $497,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

Stay updated on Investment House LLC with notifications on news.